Paula Ragan Ph.D.
Net Worth
Last updated:
What is Paula Ragan Ph.D. net worth?
The estimated net worth of Dr. Paula Ragan Ph.D. is at least $6,760,457 as of 15 Nov 2024. He owns shares worth $2,961,978 as insider, has earned $1,040,629 from insider trading and has received compensation worth at least $2,757,850 in X4 Pharmaceuticals, Inc..
What is the salary of Paula Ragan Ph.D.?
Dr. Paula Ragan Ph.D. salary is $551,570 per year as Founder, Chief Executive Officer, Pres, Sec. & Director in X4 Pharmaceuticals, Inc..
How old is Paula Ragan Ph.D.?
Dr. Paula Ragan Ph.D. is 55 years old, born in 1970.
What stocks does Paula Ragan Ph.D. currently own?
As insider, Dr. Paula Ragan Ph.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| X4 Pharmaceuticals, Inc. (XFOR) | Founder, Chief Executive Officer, Pres, Sec. & Director | 993,919 | $2.98 | $2,961,978 |
What does X4 Pharmaceuticals, Inc. do?
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase III clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome; and Phase Ib clinical trial to treat chronic neutropenia and Waldenström macroglobulinemia. The company is also developing X4P-002, a CXCR4 antagonist for the treatment of brain cancers; and X4P-003, a CXCR4 antagonist for the treatment of CXCR4 disorders and primary immunodeficiencies. It has a license agreement with Abbisko Therapeutics Co., Ltd. to develop, manufacture, and commercialize mavorixafor in combination with checkpoint inhibitors or other agents in oncology indications. The company was founded in 2010 and is headquartered in Boston, Massachusetts.
Paula Ragan Ph.D. insider trading
X4 Pharmaceuticals, Inc.
Dr. Paula Ragan Ph.D. has made 39 insider trades between 2020-2024, according to the Form 4 filled with the SEC. Most recently he sold 31,897 units of XFOR stock worth $12,599 on 15 Nov 2024.
The largest trade he's ever made was exercising 239,436 units of XFOR stock on 7 Oct 2024. As of 15 Nov 2024 he still owns at least 993,919 units of XFOR stock.
X4 Pharmaceuticals key executives
X4 Pharmaceuticals, Inc. executives and other stock owners filed with the SEC:
- Dr. Paula Ragan Ph.D. (55) Founder, Chief Executive Officer, Pres, Sec. & Director
- Mr. Adam S. Mostafa (45) Chief Financial Officer, Treasurer & Assistant Sec.
- Mr. Derek M. Meisner Esq., J.D. (54) Chief Legal Officer & Corporation Sec.